Institutional investors purchased a net $2.4 million shares of SUPN during the quarter ended June 2017, and now own 97.49% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 984.2 Thousand shares of Supernus Pharmaceuticals ...